Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
ATTAIN-1 enrolled 3,127 adults with obesity or overweight who did not have type 2 diabetes
Obese mice were treated with semaglutide or a GLP-1/glucagon dual agonist (survodutide) and then had one limb immobilized with a cast for 7 days
Anyone who has had cancer, even years ago, faces a different risk calculus than someone without cancer history
Note: Figures and projections outlined in this report are the result of Polaris Market Researchs proprietary analytical processes, grounded in the latest available datasets and market observations
Organizations involved: payers/insurers, hospital specialty clinics, retail and online pharmacies, patient advocacy groups, specialty pharmacies, telemedicine providers, pharma patient-support teams, digital health vendors (adherence apps, remote monitoring), and third-party benefits managers
Mayo Clinic: Phentermine (Oral Route) Lewis KH, et al
US$ 26.59
US$ 21.16
US$ 20.17
US$ 22.94
US$ 20.82
US$ 29.39
US$ 20.49
